[Malignant mesothelioma presenting as a perineal and pelvic mass--a trial of high dose intra-arterial methotrexate injection and irradiation].
A 50-year-old male with the complaints of lumbago and voiding disturbance was diagnosed to have malignant mesothelioma. Serum CA-125 was found to be elevated. The tumor was stained positive immunohistochemically only for CA-125 and epithelial membrane antigen. Magnetic resonance imaging of the pelvic demonstrated a large mass extending from the right external obturator muscle to the perineum. He was treated by two courses of methotrexate given intra-arterially (2,000 mg) followed by external beam irradiation at a total dose of 60 Gy. Disease progression was not apparent 15 months after treatment.
Matsumoto
K
K
Department of Urology, Kisatato University School of Medicine.
Yoshida
K
K
Egawa
S
S
Minei
S
S
Hirai
S
S
Baba
S
S
Kuwao
S
S
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D014408:Biomarkers, Tumor / Q000032:analysis; D018394:CA-125 Antigen / Q000032:analysis; D003131:Combined Modality Therapy; D006801:Humans; D007269:Injections, Intra-Arterial; D008279:Magnetic Resonance Imaging; D008297:Male; D008654:Mesothelioma / Q000188:drug therapy* / Q000532:radiotherapy; D008727:Methotrexate / Q000008:administration & dosage*; D008875:Middle Aged; D018396:Mucin-1 / Q000032:analysis; D010386:Pelvic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D010502:Perineum; D020551:Pulse Therapy, Drug; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D014408:Biomarkers, Tumor; D018394:CA-125 Antigen; D018396:Mucin-1; D008727:Methotrexate